Schedule 13D ownership disclosure
Enliven Therapeutics Inc
Security class unavailable · CUSIP: 29337E102
Event date: 2024-02-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,200,634
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-024915
- Form type
- SC 13D
- Filer
- 5AM Ventures VI, L.P.
- CIK
- CIK 1753037
- Filed
- Feb 16, 2024
- Reporting period
- Feb 14, 2024
- Description
- Schedule 13D beneficial ownership